The Sodium Chloride Injection, cataloged under National Stock Number 6505-01-239-2458, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Lyphomed Inc Div of Fujisawa Usa Inc. Government technical data includes 8 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 5 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-239-2458 |
| Primary Part Number | 139-20 |
| Item Name | Sodium Chloride Injection |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Lyphomed Inc Div of Fujisawa Usa Inc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Therapeutic Equivalent | NOT LISTED |
| Administration | INTRAVENOUS |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | 14.600 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 100 |
| Primary Container Content Quantity | 20.000 MILLILITERS |
| Features Provided | STERILE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| 139-20 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
| NDC00469-1390-40 | Lyphomed Inc Div of Fujisawa Usa Inc (USA) |
NSN 6505-01-239-2458 is a Sodium Chloride Injection, manufactured by Lyphomed Inc Div of Fujisawa Usa Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-239-2458 has 2 cross-referenced part numbers: 139-20 (Lyphomed Inc Div of Fujisawa Usa Inc), NDC00469-1390-40 (Lyphomed Inc Div of Fujisawa Usa Inc).
There are 5 known substitutes for 6505-01-239-2458: 5330-00-090-8499, 3455-00-254-8470, 2520-00-695-8971 and 2 more. Verify interchangeability with system specifications before substitution.
Key specifications for 139-20: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Therapeutic Equivalent: NOT LISTED; Special Features: 2.5 MEQ PER ML; SINGLE DOSE FLIPTOP VIAL; PRESERVATIVE-FREE; Administration: INTRAVENOUS. 9 total characteristics are documented in the Federal Logistics Information System.